Zai Lab Stock Analysis

Zai Stock Analysis Notes

About 34.0% of the company outstanding shares are owned by institutional investors. The book value of Zai Lab was at this time reported as 6.87. The company recorded a loss per share of 1.9. Zai Lab had not issued any dividends in recent years. Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China. Zai Lab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1951 people. For more information please call the company at 86 21 6163 2588 or visit https://www.zailaboratory.com.

Zai Lab Investment Alerts

Zai Lab Upcoming and Recent Events

Zai Largest EPS Surprises

View All Earnings Estimates

Zai Lab Environmental, Social, and Governance (ESG) Scores

Zai Lab Thematic Classifications

Zai Stock Institutional Investors

Note, although Zai Lab's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Zai Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.92 B.

Zai Profitablity

The company has Profit Margin (PM) of (0.47) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.42) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.42.

Management Efficiency

Zai Lab has return on total asset (ROA) of (0.1329) % which means that it has lost $0.1329 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2897) %, meaning that it created substantial loss on money invested by shareholders. Zai Lab's management efficiency ratios could be used to measure how well Zai Lab manages its routine affairs as well as how well it operates its assets and liabilities. As of January 5, 2026, Return On Tangible Assets is expected to decline to -0.22. In addition to that, Return On Capital Employed is expected to decline to -0.3. At present, Zai Lab's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 163.3 M, whereas Total Assets are forecasted to decline to about 809.5 M.

Technical Drivers

As of the 5th of January, Zai Lab maintains the Mean Deviation of 1.88, market risk adjusted performance of (0.97), and Standard Deviation of 2.51. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zai Lab, as well as the relationship between them.

Zai Lab Price Movement Analysis

Zai Lab Insider Trading Activities

Zai Lab Outstanding Bonds

Zai Lab Predictive Daily Indicators

Zai Lab Corporate Filings

Zai Lab Forecast Models

Zai Lab's time-series forecasting models are one of many Zai Lab's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zai Lab's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Zai Lab Bond Ratings

Zai Lab financial ratings play a critical role in determining how much Zai Lab have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Zai Lab's borrowing costs.

Zai Lab Debt to Cash Allocation

Zai Lab currently holds 153.47 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Zai Lab has a current ratio of 7.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Zai Lab's use of debt, we should always consider it together with its cash and equity.

Zai Lab Total Assets Over Time

Zai Lab Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Zai Lab uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Zai Lab Debt Ratio

12.0

It appears most of the Zai Lab's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Zai Lab's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Zai Lab, which in turn will lower the firm's financial flexibility.

Zai Lab Corporate Bonds Issued

Zai Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Zai Lab prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zai shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Zai Lab. By using and applying Zai Stock analysis, traders can create a robust methodology for identifying Zai entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Zai analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Zai analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Zai Lab stock analysis indicators help investors evaluate how Zai Lab stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Zai Lab shares will generate the highest return on investment. By understating and applying Zai Lab stock analysis, traders can identify Zai Lab position entry and exit signals to maximize returns.

When running Zai Lab's price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.